MoneyWorks4Me

Parabolic Drugs - Quaterly Results

23 Oct 2020 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended June 2020, as compared to corresponding quarter of last year.The Net Loss for the quarter ended June 2020 is Rs. -72.20 millions as compared to Net Loss of Rs. -74.90 millions of corresponding quarter ended June 2019 Operating profit Margin for the quarter ended June 2020 improved to -17.10% as compared to -19.40% of corresponding quarter ended June 2019


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202006 201906 % Var 202006 201906 % Var 202003 201903 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 180.80 0.00
Other Income 0.00 0.10 0.00 0.00 0.10 0.00 0.20 8.00 -97.50
PBIDT -17.10 -19.40 -11.86 -17.10 -19.40 -11.86 -63.90 -139.50 -54.19
Interest 1.70 1.60 6.25 1.70 1.60 6.25 6.60 34.60 -80.92
PBDT -18.80 -21.00 -10.48 -18.80 -21.00 -10.48 -70.50 -192.90 -63.45
Depreciation 53.40 55.60 -3.96 53.40 55.60 -3.96 215.90 225.20 -4.13
PBT -72.20 -76.60 -5.74 -72.20 -76.60 -5.74 -286.40 -418.10 -31.50
TAX 0.00 -1.70 0.00 0.00 -1.70 0.00 0.00 -4.10 0.00
Deferred Tax 0.00 -1.70 0.00 0.00 -1.70 0.00 0.00 -4.10 0.00
PAT -72.20 -74.90 -3.60 -72.20 -74.90 -3.60 -286.40 -414.00 -30.82
Equity 618.90 618.90 0.00 618.90 618.90 0.00 618.90 618.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -77.16 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..